IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate.
Takano K, Saeki C, Oikawa T, Hidaka A, Mizuno Y, Ishida J, Takakura K, Nakano M, Torisu Y, Amano K, Ishikawa T, Zeniya M, Tsubota A, Saruta M.
Takano K, et al. Among authors: nakano m.
J Gastroenterol Hepatol. 2020 Apr;35(4):663-672. doi: 10.1111/jgh.14900. Epub 2019 Dec 11.
J Gastroenterol Hepatol. 2020.
PMID: 31677185